{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:07:13Z","timestamp":1791612433259,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.4065\/mcp.2010.0681","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T18:34:49Z","timestamp":1309458889000},"page":"615-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority Comparison"],"prefix":"10.4065","volume":"86","author":[{"given":"Robert J.","family":"Tanenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Risser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna","family":"Ahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Skljarevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra K.","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.4065\/mcp.2010.0681_bib1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy","volume":"18","author":"Schmader","year":"2002","journal-title":"Clin J Pain"},{"issue":"2B","key":"10.4065\/mcp.2010.0681_bib2","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1016\/S0002-9343(99)00009-1","article-title":"Diabetic neuropathy: pathogenesis and therapy","volume":"107","author":"Vinik","year":"1999","journal-title":"Am J Med"},{"issue":"1-2","key":"10.4065\/mcp.2010.0681_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(02)00368-8","article-title":"Descending modulation in persistent pain: an update","volume":"100","author":"Ren","year":"2002","journal-title":"Pain"},{"issue":"3","key":"10.4065\/mcp.2010.0681_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clpt.2003.09.019","article-title":"Cyclic antidepressants and the risk of sudden cardiac death","volume":"75","author":"Ray","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.4065\/mcp.2010.0681_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0002-9343(99)00301-0","article-title":"Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents","volume":"108","author":"Cohen","year":"2000","journal-title":"Am J Med"},{"key":"10.4065\/mcp.2010.0681_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacological management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"issue":"1","key":"10.4065\/mcp.2010.0681_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain evidence from randomized, placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"issue":"1","key":"10.4065\/mcp.2010.0681_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.1993.4","article-title":"LY248686, a new inhibitor of serotonin and norepinephrine uptake","volume":"8","author":"Wong","year":"1993","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.4065\/mcp.2010.0681_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.4065\/mcp.2010.0681_bib10","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug, gabapentin (Neurontin), binds to the \u03b12-\u03b4 subunit of a calcium channel","volume":"271","author":"Gee","year":"1996","journal-title":"J Biol Chem"},{"issue":"6","key":"10.4065\/mcp.2010.0681_bib11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0277-9536(02)00132-6","article-title":"Sociological influences on antidepressant prescribing","volume":"56","author":"Sleath","year":"2003","journal-title":"Soc Sci Med"},{"issue":"11","key":"10.4065\/mcp.2010.0681_bib12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"key":"10.4065\/mcp.2010.0681_bib13","series-title":"Lyrica\u00ae United States prescribing information","year":"2007"},{"key":"10.4065\/mcp.2010.0681_bib14","series-title":"Lyrica\u00ae Canadian product monograph","year":"2007"},{"issue":"2","key":"10.4065\/mcp.2010.0681_bib15","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"issue":"3","key":"10.4065\/mcp.2010.0681_bib16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck Depression Inventories -I and -II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"J Pers Assess"},{"issue":"suppl 3","key":"10.4065\/mcp.2010.0681_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11","author":"Sheehan","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"issue":"1-2","key":"10.4065\/mcp.2010.0681_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"issue":"5","key":"10.4065\/mcp.2010.0681_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","article-title":"A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain","volume":"6","author":"Raskin","year":"2005","journal-title":"Pain Med"},{"issue":"8","key":"10.4065\/mcp.2010.0681_bib20","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","article-title":"A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain","volume":"67","author":"Wernicke","year":"2006","journal-title":"Neurology"},{"key":"10.4065\/mcp.2010.0681_bib21","author":"European Medicines Agency"},{"issue":"10","key":"10.4065\/mcp.2010.0681_bib22","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jama.295.10.1152","article-title":"Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT Statement","volume":"295","author":"Piaggio","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.4065\/mcp.2010.0681_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jpainsymman.2005.04.009","article-title":"Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep","volume":"30","author":"Gore","year":"2005","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.4065\/mcp.2010.0681_bib24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"issue":"2","key":"10.4065\/mcp.2010.0681_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpain.2007.05.003","article-title":"Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study","volume":"12","author":"T\u00f6lle","year":"2008","journal-title":"Eur J Pain"},{"issue":"8","key":"10.4065\/mcp.2010.0681_bib26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1526-4637.2008.00423.x","article-title":"Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial","volume":"9","author":"Stacey","year":"2008","journal-title":"Pain Med"},{"issue":"21","key":"10.4065\/mcp.2010.0681_bib27","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"issue":"11","key":"10.4065\/mcp.2010.0681_bib28","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.4065\/mcp.2010.0681_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"issue":"3","key":"10.4065\/mcp.2010.0681_bib30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"10.4065\/mcp.2010.0681_bib31","article-title":"The vital link between chronic disease and depressive disorders [serial online]","author":"Chapman","year":"2005","journal-title":"Prev Chronic Dis"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611600670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611600670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T04:59:03Z","timestamp":1675918743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611600670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0025619611600670"],"URL":"https:\/\/doi.org\/10.4065\/mcp.2010.0681","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority Comparison","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/mcp.2010.0681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}